← All FR Documents
Notice

Center for Scientific Review; Notice of Closed Meetings

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-03877
TypeNotice
PublishedMar 11, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (873 words · ~5 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>Center for Scientific Review; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Brain Disorders and Clinical Neuroscience Integrated Review Group; Clinical Neuroplasticity and Neurotransmitters Study Section. <E T="03">Date:</E> April 7-8, 2025. <E T="03">Time:</E> 9:00 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Suzan Nadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-1259, email: <E T="03">nadis@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Infectious Diseases and Immunology A Integrated Review Group; Molecular and Structural Immunology Study Section. <E T="03">Date:</E> April 8-9, 2025. <E T="03">Time:</E> 9:30 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Velasco Cimica, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-1760, email: <E T="03">velasco.cimica@nih.gov</E> . <E T="03">Name of Committee:</E> Infectious Diseases and Immunology A Integrated Review Group; Innate Immunity B Study Section. <E T="03">Date:</E> April 9-10, 2025. <E T="03">Time:</E> 9:30 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Bakary Drammeh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 805-P, Bethesda, MD 20892, (301) 435-0000, email: <E T="03">drammehbs@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Cardiovascular and Respiratory Sciences Integrated Review Group; Therapeutic Development and Preclinical Studies Study Section. <E T="03">Date:</E> April 10-11, 2025. <E T="03">Time:</E> 9:00 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Richard D. Schneiderman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-402-3995, email: <E T="03">richard.schneiderman@nih.gov</E> . <E T="03">Name of Committee:</E> Digestive, Kidney and Urological Systems Integrated Review Group; Digestive System Host Defense, Microbial Interactions and Immune and Inflammatory Disease Study Section. <E T="03">Date:</E> April 16-17, 2025. <E T="03">Time:</E> 8:00 a.m. to 8:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Aiping Zhao, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2188, Bethesda, MD 20892-7818, (301) 435-0682, <E T="03">zhaoa2@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Population Sciences and Epidemiology Integrated Review Group; Cancer and Hematologic Disorders Study Section. <E T="03">Date:</E> April 16-17, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Steven M. Frenk, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, (301) 480-8665, email: <E T="03">frenksm@mail.nih.gov</E> . <E T="03">Name of Committee:</E> Infectious Diseases and Immunology A Integrated Review Group; HIV Molecular Virology, Cell Biology, and Drug Development Study Section. <E T="03">Date:</E> April 24-25, 2025. <E T="03">Time:</E> 10:00 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435-1166, email: <E T="03">roebuckk@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Infectious Diseases and Immunology B Integrated Review Group; Etiology, Diagnostic, Intervention and Treatment of Infectious Diseases Study Section. <E T="03">Date:</E> May 1-2, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Contact Person:</E> Liangbiao Zheng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD 20892, 301-996-5819, email: <E T="03">zhengli@csr.nih.gov</E> . <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: March 6, 2025.</DATED> <NAME>Bruce A. George,</NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-03877 Filed 3-10-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.